News

1 2 3 4 5 ...nextlast

EU News - October 19

This week's EU newsletter covers the new work programme for H2020, EU Research Policy Making and the announcement of our new EU TechTransfer colleague Anneke Geyzen. Click here to read the newsletter or…

Qbic collects venture capital for start ups

The Qbic fund collected 8 million euros from Flemish entrepreneurs and research institutions, under which Jules Noten (CEO Vandemoortele), the family Santens and company Televic. The amount will be used…

Project call Anticipate - Prospective Research 2018

Through the Anticipate programme, Innoviris finances projects of academic researchers at a Brussels university or college with a forward-looking vision in domains that are important to the Brussels-Capital…

Aftermath IOF-TTO event

Our annual IOF-TTO event for IOF researchers & business developers and all TTO staff on October 17, was a fruitful day. The challenges in a data-driven economy are growing and the GDPR compliance implements…

Project call Launch Brussels spin-off 2018

Since its launch in 2006, the programme Launch has been a great success with 21 spin-offs created. Its goal is to stimulate and support the creation of new companies in the Brussels-Capital Region. …

VUB spin-off Camel IDS uses camel antibodies to fight cancer

After Ablynx, Argenx and Confo Therapeutics, Camel IDS is also working on a drug based on camel antibodies. The biotech company and VUB spin-off, develops a treatment that strikes cancer cells from inside…

Launch ICAB-X 2018 open call - Oct 23

On November 1st ICAB, Business & Technology Incubator, launches the open call for ICAB-X, ICAB’s premium accelerator program for digital scale ups. We kick off the new coaching season with our launch…

Johnson & Johnson Scholars Award

Johnson & Johnson has launched the $150,000 J&J Scholars Award as part of its WiSTEM2D (Women in Science, Technology, Engineering, Math, Manufacturing, and Design) initiative.  The J&J Scholars Award…

VUB spin-off Ablynx: nanobodies might save your life

Ablynx announces positive topline results from the Phase III Hercules Study of Caplacizumab for the treatment of acquired TTP (thrombotic thrombocytopenic purpura), a rare but lethal disease.Check articles…

Fulbright award competition 2018-2019 now open

The Commission for Educational Exchange between Belgium, Luxembourg, and the U.S. is pleased to announce that the Fulbright award competition for Belgium, Luxembourg, and Schuman for academic year 2018-2019…
1 2 3 4 5 ...nextlast